login
login

Europe Daily Bulletin No. 7984

15 June 2001
Contents Publication in full By article 41 / 45
ECONOMIC INTERPENETRATION / (eu) biotechnologies

The American genetic research company CELERA GENOMICS has announced the acquisition of the biotechnologies company AXYS PHARMACEUTICALS, specialised in cancerology, for the sum of $174.4 million. Carried out through an exchange of shares, the transaction represents the equivalent of $4.65 per AXYS share.

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION